blood-microsampling-applications-pediatrics

make pediatric studies easier for everyone

 

Children (and Researchers) Prefer Remote Specimen Collection & Microsampling

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content included here.

Download Now
A needless blood sampling option for pediatric patients

At-home Specimen Collection Makes
Study Participation Easier

Children can find visits to a research facility stressful. This poses challenges for researchers and trial managers who rely on collecting bio-fluid specimens to monitor pediatric study subjects. One solution is to offer remote specimen collection, which reduces or eliminates onsite visits. Remote specimen collection can be performed by parents or another family member at home, which makes the process less stressful. The Mitra® Microsampler is a portable device designed for easy sampling at home or on the go. Samples can be mailed back to the facility via regular post for lab analysis. This remote option provides a better experience for young study participants and their families, and a convenient way for researchers to gather the high-quality samples they need to generate reliable data.

Download Now
pediatric-capillary-blood-microsampling-case-studies

Learn more about the remarkable results already being achieved by researchers at Gaslini Children's Hospital, Swiss Tropical and Public Health Institute, and others. Some case studies offered here for download discuss healthcare projects in countries outside the US, where Mitra® devices are approved for blood collection in clinical settings:

  • With home sampling, children and their caregivers can skip the drive to and from the facility for blood draws
  • Mitra® devices with VAMS® technology are used for remote blood collection to monitor therapeutic drugs and malnutrition
  • Garner the logistical benefits of using Mitra® devices vs. DBS cards in low-resource regions around the globe
  • Simplify blood collection in pediatric study subjects by switching to at-home finger-prick sampling to reduce needle anxiety

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Trajan_logo_footer_wht

Contact Us
Trajan Scientific Americas Inc.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine. 

In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. 

Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group. 

Copyright © 2022. All rights reserved.